Marker Therapeutics Inc (MRKR)

[microcapbiotech]

going to vent - don't read if not want to.

OK, I get like this sometimes, mostly after I spend days looking at small biotech companies, and I always see the same thing, and I think about Marker, and it just upsets me so much.

OK, there were two bio's that did IPO's today, and a few that have IPO'ed since March 2020.

AND THEY ALL HAVE THE SAME THING IN COMMON.

I just looked at like 20 small biotechs, ALL SAME THING.

Now, on one of them, our friends NEA was the top $ early investor and is now up like 800% on that one … and good for them.

BUT, what they ALL have in common, is they ALL have NOTHING, they are ALL pre-clinical, and they ALL have market caps from 800 MILLION to 2.4 BILLION.

Marker with actual FDA trials underway, with (I hope) great potential, a real biotech that actual HAS something besides "this is what we are going to try", has a market cap of 100 million.

I mean seriously, one of them said that they won't be starting their first trial until MID 2022 … and they are worth over a BILLION?

How can I not just be livid?

If these "have nothing, doing nothing" companies are worth 1 or 2 billion, HELL, WHAT SHOULD MRKR BE WORTH IN COMPARISON? 10 BILLION?

This is just BS and I needed to say it.